Effects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats

No abstract is available for this paper.

• Publication year

  2011

• Venue

  British Journal of Pharmacology

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1476-5381.2010.01031.xPMID 20840471PMCID PMC3012414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Guide to Receptors and Channels (GRAC), 5th edition

  2011cited by this paper
• Rho kinase inhibition protects kidneys from diabetic nephropathy without reducing blood pressure.

  2011cited by this paper
• Effect of Protein Kinase Cβ Inhibition on Renal Hemodynamic Function and Urinary Biomarkers in Humans With Type 1 Diabetes: A Pilot Study

  2009cited by this paper
• Rho-kinase inhibition reduces pressure-mediated autoregulatory adjustments in afferent arteriolar diameter.

  2009cited by this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cited by this paper
• Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis

  2009cited by this paper
• ROCK Isoform Regulation of Myosin Phosphatase and Contractility in Vascular Smooth Muscle Cells

  2009cited by this paper
• RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease

  2008influential reference
• Targeting of RhoA/ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose Control

  2008influential reference
• Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision).

  2007cited by this paper
• Crucial role of Rho-nuclear factor-kappaB axis in angiotensin II-induced renal injury.

  2007cited by this paper
• Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.

  2007cited by this paper
• Anti-ischemic Effects of Fasudil, a Specific Rho-Kinase Inhibitor, in Patients With Stable Effort Angina

  2007cited by this paper
• The role of protein kinase C activation and the vascular complications of diabetes.

  2007cited by this paper
• Long-Term Administration of Rho-Kinase Inhibitor Ameliorates Renal Damage in Malignant Hypertensive Rats

  2006cited by this paper
• Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure.

  2006influential reference
• Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney

  2006cited by this paper
• Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells.

  2006cited by this paper
• Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury.

  2006cited by this paper
• Role of Rho-Kinase and p27 in Angiotensin II–Induced Vascular Injury

  2005cited by this paper
• RhoA and resistance artery remodeling.

  2005influential reference
• The effect of ruboxistaurin on nephropathy in type 2 diabetes.

  2005cited by this paper
• Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells

  2005cited by this paper
• High Glucose-Induced Upregulation of Osteopontin Is Mediated via Rho/Rho Kinase Pathway in Cultured Rat Aortic Smooth Muscle Cells

  2004cited by this paper
• Fasudil, a Rho-kinase inhibitor, attenuates glomerulosclerosis in Dahl salt-sensitive rats

  2004cited by this paper
• , Seiji Protein Kinase C Protein Kinase A as Another Mediator of Ischemic Preconditioning Independent of

  2004cited by this paper
• Vessel- and Vasoconstrictor-Dependent Role of Rho/Rho-Kinase in Renal Microvascular Tone

  2003influential reference
• Sphingosine Kinase Modulates Microvascular Tone and Myogenic Responses Through Activation of RhoA/Rho Kinase

  2003cited by this paper
• Variations in cell signaling pathways for different vasoconstrictor agonists in renal circulation of the rat.

  2003cited by this paper
• Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase.

  2003influential reference
• Effects of angiotensin II, arginine vasopressin and tromboxane A2 in renal vascular bed: role of rho-kinase.

  2003influential reference
• Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.

  2003cited by this paper
• Effect of fasudil on Rho-kinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats.

  2003cited by this paper
• Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.

  2003cited by this paper
• Increased RhoA translocation in renal cortex of diabetic rats.

  2003cited by this paper
• Protein Kinase C (cid:1) -Induced p115RhoGEF Phosphorylation Signals Endothelial Cytoskeletal Rearrangement*

  2003cited by this paper
• Upregulation of small GTPase RhoA in the basilar artery from diabetic (mellitus) rats.

  2002cited by this paper
• Important Role of Rho-kinase in the Pathogenesis of Cardiovascular Inflammation and Remodeling Induced by Long-Term Blockade of Nitric Oxide Synthesis in Rats

  2002cited by this paper
• Protein Kinase C-α Signals Rho-Guanine Nucleotide Dissociation Inhibitor Phosphorylation and Rho Activation and Regulates the Endothelial Cell Barrier Function*

  2001cited by this paper
• Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats.

  2000cited by this paper
• Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

  2000cited by this paper
• Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality.

  1999cited by this paper
• M3 Muscarinic Acetylcholine Receptors Regulate Cytoplasmic Myosin by a Process Involving RhoA and Requiring Conventional Protein Kinase C Isoforms*

  1999influential reference
• Physiologic Actions and Molecular Expression of the Renin-Angiotensin System in the Diabetic Rat

  1998cited by this paper
• Protein kinase C activation and the development of diabetic complications.

  1998cited by this paper
• Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.

  1997cited by this paper
• Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

  1997cited by this paper
• Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

  1996influential reference
• Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.

  1996cited by this paper
• Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)*

  1996cited by this paper
• Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR.

  1994cited by this paper
• Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations.

  1993cited by this paper
• Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes.

  1990cited by this paper
• Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

  1986cited by this paper
• J Am Soc Nephrol 13: 37–45, 2003 Rho-Kinase Inhibition Blunts Renal Vasoconstriction Induced by Distinct Signaling Pathways In Vivo

  year unknowninfluential reference

• Shared signaling pathways and comprehensive therapeutic approaches among diabetes complications

  2025cites this paper
• Harnessing ROCK biology to revolutionize diabetic nephropathy: decoding mechanisms, designing therapies

  2025cites this paper
• Effects of a protein kinase C epsilon inhibitor on insulin signalling in lipid-treated HepG2 hepatocytes and glucose tolerance in fat-fed mice.

  2025cites this paper
• Fasudil on Myocardial Injury in Rats with Myocardial Ischemia and Reperfusion through Rho-ROCK Signal Pathway.

  2022cites this paper
• A natural products solution to diabetic nephropathy therapy.

  2022cites this paper
• NLRP3-mediated pyroptosis in diabetic nephropathy

  2022cites this paper
• ROCK2 Inhibition: A Futuristic Approach for the Management of Alzheimer's Disease.

  2022cites this paper
• Activin A and Cell-Surface GRP78 Are Novel Targetable RhoA Activators for Diabetic Kidney Disease

  2021cites this paper
• Biologically active isoquinoline alkaloids covering 2014–2018

  2020cites this paper
• Druggable targets in the Rho pathway and their promise for therapeutic control of blood pressure

  2019cites this paper
• Protective Actions of Oxytocin on Aortic Wistar and SHR VSMCs

  2019cites this paper
• Rho‐associated protein kinases as therapeutic targets for both vascular and parenchymal pathologies in Alzheimer's disease

  2018cites this paper
• Vascular smooth muscle contraction in hypertension

  2018cites this paper
• Oxidative stress induced by prenatal LPS leads to endothelial dysfunction and renal haemodynamic changes through angiotensin II/NADPH oxidase pathway: Prevention by early treatment with α-tocopherol.

  2018cites this paper
• Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells.

  2016cites this paper
• Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms.

  2015cites this paper
• Blocking VEGF/Caveolin-1 signaling contributes to renal protection of fasudil in streptozotocin-induced diabetic rats

  2015cites this paper
• Rho kinase inhibition in diabetic kidney disease

  2013cites this paper
• Targeting of Rho Kinase Ameliorates Impairment of Diabetic Endothelial Function in Intrarenal Artery

  2013influential citation
• Molecular targets in the discovery and development of novel antimetastatic agents: Current progress and future prospects

  2013cites this paper
• Activation of RhoA/ROCK regulates NF-κB signaling pathway in experimental diabetic nephropathy.

  2013cites this paper
• Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.

  2013cites this paper
• Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.

  2013cites this paper
• Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.

  2013cites this paper
• Potential Benefits of Rho-kinase Inhibition in Arterial Hypertension

  2013cites this paper
• Rho kinase inhibitors: potential treatments for diabetes and diabetic complications.

  2012cites this paper
• Myosin Light Chain Kinase Is Involved in the Mechanism of Gastrointestinal Dysfunction in Diabetic Rats

  2012cites this paper
• The ADF/Cofilin-Pathway and Actin Dynamics in Podocyte Injury

  2011influential citation
• ROCK Inhibition – A New Therapeutic Avenue in Kidney Protection

  2011influential citation
• Rho kinase inhibition in diabetic nephropathy

  2011cites this paper
• Pathophysiology of the diabetic kidney.

  2011cites this paper
• Long‐term diabetic complications may be ameliorated by targeting Rho kinase

  2011cites this paper